Transcode Therapeutics, Inc. · NASDAQ:RNAZ
Transcode Therapeutics, Inc. shareholders
As of Jun 30, 2026, 7 institutions reported holding Transcode Therapeutics, Inc., 0.20% of its shares. Largest: Yorkville Advisors Global, LP, Vanguard and UBS. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Transcode Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Yorkville Advisors Global, LP | 19,639 | 0.12% | held for review | Aug 6, 2026 |
| Vanguard | 9,527 | 0.06% | no change | Aug 13, 2026 |
| UBS | 2,888 | 0.02% | −5,407 | Aug 13, 2026 |
| Fidelity | 706 | <0.01% | new | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 677 | <0.01% | +449 | Aug 11, 2026 |
| Wells Fargo | 55 | <0.01% | no change | Aug 14, 2026 |
| SBI Securities Co., Ltd. | 12 | <0.01% | no change | Jul 23, 2026 |